Helixmith ranked among the top searched stocks on 2 days within the past month.


As of 2:31 PM on the 17th, Helixmith is trading at 52,400 KRW, down 4.9% from the previous day. This represents a 14.29% increase compared to September 4. Helixmith is known as a specialized company developing new drugs focused on gene therapy.

Today, foreigners are tentatively recorded as net buyers of 3,000 shares. Over the past 5 days, individual investors have net purchased 235,533 shares, while foreigners and institutions have net sold 219,934 shares and 26,225 shares, respectively.


On September 16, Helixmith became a market issue with a 9.7% increase following the news of submitting a gene therapy clinical trial plan to the FDA.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing